Phreesia, Inc. (NASDAQ: PHR) director Lisa Egbuonu-Davis executed a sale of 2,546 shares of the company's common stock on June 25, 2026, totaling $24,263. The sale was facilitated through a Rule 10b5-1 trading plan established on December 16, 2025.
This transaction occurred shortly after Egbuonu-Davis was granted 19,290 restricted stock units (RSUs) valued at $184,991 on June 24, 2026. The shares were sold at a price of $9.53 per share. Following the sale, the director retains a direct holding of 38,316 shares.
Key Points
- Director Lisa Egbuonu-Davis sold 2,546 shares of PHR common stock for $24,263 under a pre-arranged Rule 10b5-1 plan adopted on December 16, 2025.
- The sale followed the grant of 19,290 RSUs valued at $184,991 on June 24, 2026, which vest upon the earlier of June 24, 2027, or the next annual stockholder meeting.
- Phreesia recently reported first-quarter fiscal 2027 earnings of $0.05 per share, significantly exceeding the $0.01 forecast, alongside revenue of $130.9 million that surpassed consensus estimates of $130.1 million.
Market Context and Analyst Perspectives
The stock sale comes as Phreesia shares have declined 46% over the past six months. Despite this downturn, analysis suggests the stock is currently undervalued according to InvestingPro Fair Value metrics, with the company maintaining a "GREAT" financial health score of 3.09.
On the preceding day, June 24, 2026, Ms. Egbuonu-Davis was granted 19,290 restricted stock units (RSUs) at a value of $9.59 per unit, totaling $184,991. These RSUs represent the contingent right to receive one share of Phreesia common stock each and were issued under the company’s 2019 Stock Option and Incentive Plan. The RSUs are scheduled to vest in full upon the earlier of June 24, 2027, or the next annual meeting of Phreesia’s stockholders.
Following these transactions, Ms. Egbuonu-Davis directly holds 38,316 shares of Phreesia common stock. According to InvestingPro Tips, 5 analysts have recently revised their earnings upwards for the upcoming period, signaling improving sentiment. Investors seeking deeper insights can access 10 additional ProTips and comprehensive Pro Research Reports covering PHR and 1,400+ other US equities.
In other recent news, Phreesia Inc. reported impressive financial results for the first quarter of fiscal year 2027, exceeding earnings expectations. The company achieved an EPS of $0.05, significantly surpassing the forecasted $0.01. Phreesia’s total revenue reached $130.9 million, slightly above the consensus estimate of $130.1 million. Analysts at Citizens maintained a Market Perform rating on Phreesia following these results, while DA Davidson reiterated a Buy rating with a $14.00 price target. PhreesiaFollowAnalyze PHRIncluded in our AI-picked strategies·Review strategies10.02▲+0.89(+9.75%)Closed·15:59:59·USD10.070.00(0.00%)After Hours·16:34:101D1W1M6M1Y5YMaxCreated with Highcharts 11.4.814:0015:0016:0017:0018:0019:0099.259.59.7510Analyze PHRConversely, Piper Sandler downgraded the stock to Neutral from Overweight, adjusting the price target to $12 due to a shift in profitability outlook. Truist Securities raised its price target on Phreesia to $12.00 from $11.00, maintaining a Hold rating. Despite the mixed analyst ratings, Phreesia’s management upheld its full-year fiscal 2027 revenue guidance, indicating a 1% organic revenue growth at the midpoint. These developments highlight a diverse analyst perspective on Phreesia’s future performance.
Risks and Uncertainties
- Phreesia shares have declined 46% over the past six months, indicating significant recent price volatility that may impact investor confidence and market perception.
- Analyst sentiment remains divided, with Piper Sandler downgrading the stock to Neutral from Overweight due to a shift in profitability outlook, while other firms maintain positive ratings.
- The company's future performance faces scrutiny from diverse analyst perspectives, requiring careful monitoring of the 1% organic revenue growth guidance and its achievability.
Investment Data and Market Activity
The transaction details are as follows:
| Date | Transaction Type | Shares/Units | Price per Share/Unit | Total Value |
|---|---|---|---|---|
| June 25, 2026 | Sale | 2,546 | $9.53 | $24,263 |
| June 24, 2026 | RSU Grant | 19,290 | $9.59 | $184,991 |
Post-transaction holdings for Ms. Egbuonu-Davis stand at 38,316 shares of Phreesia common stock.